The Hitchhiker's Guide to Venture Capital

Romans' VC blog with musings and stories related to venture capital, growing value and M&A. Author of McGraw Hill August 2013 published book - THE ENTREPRENEURIAL BIBLE TO VENTURE CAPITAL: Inside Secrets from the Leaders in the Startup Game - available on Amazon, Barnes & Nobel, iTunes and other online and offline stores. Full blog posts are posted to http://rubicon.vc/blog/.

  • Home
    Home This is where you can find all the blog posts throughout the site.
  • Categories
    Categories Displays a list of categories from this blog.
  • Tags
    Tags Displays a list of tags that has been used in the blog.
  • Bloggers
    Bloggers Search for your favorite blogger from this site.
  • Team Blogs
    Team Blogs Find your favorite team blogs here.
  • Login

List of the Most Active VCs in Healthcare & Life Science - Biotech Part 1 of 6

Posted by on in Uncategorized
  • Font size: Larger Smaller
  • Hits: 275506
  • Subscribe to this entry
  • Print
  • PDF
  • Report this post

Every year during the second week of January venture capitalists, investment bankers and entrepreneurs take over Union Square and the surrounding few blocks of San Francisco during the J.P. Morgan Healthcare Conference.  The J.P. Morgan event itself, now in its 31st year, has become less relevant as most of the 10,000+ executives in the city come for 1:1 meetings and countless other events that take place during that week. Literally every hotel ballroom, suite, lobby, bar, restaurant and art gallery is pre-booked or filled with deal-makers pitching each other and determining which companies in the healthcare & life science sector will be funded, sold or IPO’d that year. Every night has countless bumper to bumper parties sponsored by top investment banks, VCs and law firms, some as lavish as weddings in every ball room or bar within a 5 block radius of Union Square.

The Founders Club itself is hosting an event at the offices of Wilson Sonsini Goodrich & Rosati (WSGR) Tuesday night January 8th. Get in touch if you would like to attend. Priority will go to VCs, angles, CEOs, founders, corporate development execs and key partners. http://goo.gl/eCD96.

It is the only time of year for me when almost every active healthcare life science related VC and CEO I know from San Diego to Stockholm is in the same city at the same time. I rarely set foot in the Westin St. Francis Hotel for the J.P. Morgan event, but typically pre-book myself for every breakfast, lunch, dinner and each time slot in between with 40+ meetings that week.

With the largest investor summit of the year for the sector only a few weeks away (January 6 – 9, 2013) I’ve decided to dedicate the next few blog posts to the healthcare & life science sector. Even if you are an IT or cleantech professional I suggest taking a look at insights gleaned from the biotech & medical device sectors. It is more relevant to IT entrepreneurship and other markets than you might think. The biotech sector has always practiced the ideals of the Lean Startup and minimum viable product (MVP) and so much of the biotech secretes cross over nicely to other venture backed technology sectors. Just as technology is finally infiltrating education, IT technology, the Internet and mobility are also making a major impact in healthcare markets and some consumer and enterprise technology entrepreneurs and VCs may find themselves entering the fray of healthcare deal-making.

The next few posts will include insights from key venture capitalists active in the healthcare life science sectors, but let me begin with a list of the most active VCs in the biotech sector.

These are the most active investors that have invested in biotech companies that, as individual portfolio companies, raised a minimum of $15m, each having completed investment rounds in the five-year period ranging from 2007 to 2011.  They are ranked by the number of companies invested. My book includes the most up to date lists of active investors including multiple league tables illustrating the most active VCs broken down by different categories including medical devices, geographies and different funding amounts. We have a bunch of these VCs on the advisory board of The Founders Club. Here are the facts.

1 Domain Associates LLC Princeton, NJ US$ 2,466 39
2 Novartis Venture Fund Basel, Switzerland US$ 650 39
3 MPM Capital Boston, MA US$ 2,500 36
4 Alta Partners San Francisco, CA US$ 1,871 35
5 Novo A/S Hellerup, Denmark US$ 2,044 31
6 OrbiMed Advisors LLC New York, NY US$ 6,000 28
7 New Enterprise Associates Timonium, MD US$ 10,650 25
8 Clarus Ventures LLC Cambridge, MA US$ 1,200 22
9 S.R. One Ltd. Conshohocken US$ 322 22
10 SV Life Sciences Advisers LLC Boston, MA US$ 2,062 22
11 HBM BioVentures AG Zug, Switzerland US$ 2,404 21
12 Polaris Venture Partners Waltham, MA US$ 3,049 21
13 Atlas Venture Cambridge, MA US$ 1,973 20
14 Frazier Healthcare Ventures Seattle, WA US$ 1,800 20
15 Sofinnova Ventures San Francisco, CA US$ 975 20
16 Venrock Palo Alto, CA US$ 2,200 20
17 InterWest Partners Menlo Park, CA US$ 2,800 19
18 Versant Venture Management LLC Menlo Park, CA US$ 1,585 19
19 Abingworth Management Inc. London, United Kingdom US$ 1,250 18
20 ARCH Venture Partners LP Chicago, IL US$ 1,500 18
21 Third Rock Ventures LLC Boston, MA US$ 804 18
22 New Leaf Venture Partners Menlo Park, CA US$ 1,300 17
23 TVM Capital GmbH Munich, Germany US$ 1,563 17
24 Canaan Partners Westport, CT US$ 3,000 16
25 Essex Woodlands Health Ventures New York, NY US$ 2,500 16
26 Flagship Ventures Cambridge, MA US$ 603 16
27 HealthCare Ventures LLC Cambridge, MA US$ 1,570 16
28 Johnson & Johnson Development Corp. New Brunswick, NJ
16
29 Kleiner Perkins Caufield & Byers Menlo Park, CA US$ 3,305 16
30 Pappas Ventures Durham, NC US$ 353 16
31 Quaker BioVentures Philadelphia, PA US$ 875 16
32 Bay City Capital San Francisco, CA US$ 1,550 14
33 Burrill & Company San Francisco, CA US$ 950 14
34 Fidelity Biosciences Cambridge, MA US$ 480 14
35 Prospect Venture Partners Palo Alto, CA US$ 1,000 14
36 Skyline Ventures Palo Alto, CA US$ 800 14
37 Texas Pacific Group Growth San Francisco, CA US$ 45,000 14
38 5AM Ventures Menlo Park, CA US$ 435 13
39 Aisling Capital New York, NY US$ 1,600 13
40 Forbion Capital Partners Naarden, Netherlands US$ 240 13
41 MedImmune Ventures, Inc. Gaithersburg, MD US$ 300 13
42 ProQuest Investments Princeton, NJ US$ 900 13
43 Lilly Ventures Indianapolis, IN US$ 550 12
44 Sofinnova Partners Paris, France US$ 1,328 12
45 Hercules Technology Growth Capital Inc. Palo Alto, CA US$ 475 11
46 Life Sciences Partners BV Amsterdam, Netherlands US$ 601 11
47 Oxford Bioscience Partners Boston, MA US$ 1,019 11
48 Wellcome Trust London, United Kingdom US$ 51,711 11
49 Amgen Ventures Thousand Oaks, CA US$ 100 10
50 Bessemer Venture Partners Larchmont, NY US$ 2,350 10

 

Here is the same search for investors in biotech firms that raised a minimum of $15m, but for transactions that closed in 2011. With much of the cash drying up for biotech I thought it useful to show who has been investing recently.  Again, my book will publish the most up to date league tables. If one included equity exchange funds, The Founders Club would rank in the top 10 VCs listed here.

1 Third Rock Ventures LLC Boston, MA US$ 804 12
2 OrbiMed Advisors LLC New York, NY US$ 6,000 8
3 Domain Associates LLC Princeton, NJ US$ 2,466 7
4 New Enterprise Associates Timonium, MD US$ 10,650 7
5 Flagship Ventures Cambridge, MA US$ 603 6
6 MPM Capital Boston, MA US$ 2,500 6
7 Novo A/S Hellerup, Denmark US$ 2,044 6
8 S.R. One Ltd. Conshohocken US$ 322 6
9 Alta Partners San Francisco, CA US$ 1,871 5
10 Clarus Ventures LLC Cambridge, MA US$ 1,200 5
11 Essex Woodlands Health Ventures New York, NY US$ 2,500 5
12 Polaris Venture Partners Waltham, MA US$ 3,049 5
13 Aisling Capital New York, NY US$ 1,600 4
14 ARCH Venture Partners LP Chicago, IL US$ 1,500 4
15 Atlas Venture Cambridge, MA US$ 1,973 4
16 Bessemer Venture Partners Larchmont, NY US$ 2,350 4
17 Canaan Partners Westport, CT US$ 3,000 4
18 Forbion Capital Partners Naarden, Netherlands US$ 240 4
19 Hercules Technology Growth Capital Inc. Palo Alto, CA US$ 475 4
20 New Leaf Venture Partners Menlo Park, CA US$ 1,300 4
21 Sofinnova Ventures San Francisco, CA US$ 975 4
22 SV Life Sciences Advisers LLC Boston, MA US$ 2,062 4
23 Texas Pacific Group Growth San Francisco, CA US$ 45,000 4
24 TVM Capital GmbH Munich, Germany US$ 1,563 4
25 Venrock Palo Alto, CA US$ 2,200 4
26 Advanced Technology Ventures Waltham, MA US$ 1,600 3
27 BB Biotech Ventures Schaffhausen, Switzerland US$ 396 3
28 Celgene NJ 3
29 Fidelity Biosciences Cambridge, MA US$ 480 3
30 Frazier Healthcare Ventures Seattle, WA US$ 1,800 3
31 Kleiner Perkins Caufield & Byers Menlo Park, CA US$ 3,305 3
32 Pappas Ventures Durham, NC US$ 353 3
33 Versant Venture Management LLC Menlo Park, CA US$ 1,585 3
34 Vivo Ventures Palo Alto, CA US$ 650 3
35 5AM Ventures Menlo Park, CA US$ 435 2
36 Abbott Laboratories Abbott Park, IL 2
37 Abingworth Management Inc. London, United Kingdom US$ 1,250 2
38 Adams Street Partners LLC Chicago, IL US$ 20,000 2
39 Aescap Venture Amsterdam, Netherlands US$ 125 2
40 Alloy Ventures Palo Alto, CA US$ 1,094 2
41 Altitude Life Science Ventures Durango 2
42 Astellas Venture Management LLC Menlo Park, CA US$ 160 2
43 Bay City Capital San Francisco, CA US$ 1,550 2
44 Cardinal Partners Princeton, NJ US$ 400 2
45 Column Group San Francisco, CA US$ 259 2
46 Credit Agricole Private Equity Paris, France US$ 4,456 2
47 Flybridge Capital Partners Boston, MA US$ 560 2
48 Forward Ventures San Diego, CA US$ 500 2
49 GE Capital Stamford, CT 2
50 HBM BioVentures AG Zug, Switzerland US$ 2,404 2

 

Don't forget to sign up to attend our event at JPM January 8, 2013.

4:30 pm: Coffee and networking
5:00 pm: Company pitches
6:00 pm to 7:30 pm: Cocktails & networking

WSGR San Francisco / Soma
139 Townsend Street
Suite 150
San Francisco, California 94107

http://goo.gl/eCD96

Rate this blog entry:
0

Andrew Romans is the co-founder and general partner of Rubicon Venture Capital (formerly Georgetown Angels), a VC fund and angel group. Romans also founded The Founders Club, a venture capital equity exchange fund that also provides liquidity solutions for founders, investors & employees with over 40 VCs on the advisory board in the US, Europe and Israel. Romans was previously a managing partner at Georgetown Venture Partners (GVP), managing director of Sentito Networks (acquired by Verso) and founder & president of The Global TeleExchange (The GTX), where he personally raised $47m in VC funding. Fluent in English, French and German, conversant in Czech and Slovak, Romans completed a BA at the University of Vermont and an MBA in finance at Georgetown University, which he completed on scholarship. Romans is also the author of THE ENTREPRENEURIAL BIBLE TO VENTURE CAPITAL, Inside Secrets from the Leaders in the Startup Game (published by McGraw Hill available in hardcover & all e-book formats in book stores and on Amazon.com, iTunes & Barnes & Nobel. Follow Romans on Twitter: @romansventures www.linkedin.com/in/romans

Comments

Under no circumstances should any material at this site be used or considered as an offer to sell or a solicitation of any offer to buy an interest in any individual company or investment fund managed by The Founders Club.  Any such offer or solicitation will be separately made only by means of the Confidential Private Offering Memorandum relating to the particular fund to persons who, among other requirements, meet certain qualifications under federal securities laws and generally are sophisticated in financial matters, such that they are capable of evaluating the merits and risks of prospective investments. Copyright © 2013 All rights Reserved http://www.founders-club.com